Skip to content

Preview

In focus: The case for Japanese equities

Japanese equities have been extending their rally, handily outperforming the global markets since the turn of the year. In the year to date as of February 29, 2024, the Nikkei 225 Index has risen 17%, breaching the all-time high recorded 34 years ago. A broader benchmark, TOPIX, similarly surged 13% over the same period, almost touching its all-time high. In comparison, the US benchmark S&P 500 Index rose almost 7% year-to-date, while the global benchmark MSCI All Country World Index rose almost 5%.1

For Templeton Global Equity Group, Japan remains a high-conviction market in 2024 as we believe corporate governance reforms continue to underpin prospects of enhanced shareholder returns; a normalizing domestic economy after three decades of deflation may prove supportive as well. However, valuations and earnings growth bear watching.

Investment outlook

In the United States, optimism about rate cuts currently dominates sentiment, but we will pay attention to capital costs and their impact on corporate fundamentals, including earnings and cash flow growth. Likewise, amid the market recovery in the Asia Pacific (APAC) region, we strive to gear our portfolios toward companies that are favorably valued relative to their future earnings power, while diversification remains a key investment priority. In Europe, we like the small- and mid-cap segment following a period of underperformance relative to the big caps. The United Kingdom is one of the markets where we see relevant opportunities.

Looking ahead, we aim to keep our portfolios generally balanced across a range of factor and style exposures, as we continue to navigate a stock-picker’s market. As always, valuation discipline and bottom-up fundamental analysis will anchor our investment decisions, but we will adopt a nuanced approach to different regions to identify their most attractive opportunities, in our view.

Market review: February 2024

Global equities rallied in February 2024. As measured by MSCI indexes in US-dollar terms, emerging market equities modestly outperformed a global index, while developed market equities slightly lagged it, and frontier market equities significantly underperformed it. Global growth stocks substantially outperformed global value stocks.

In February, generally strong fourth-quarter 2023 corporate earnings reports, enthusiasm about artificial intelligence and the potential for an economic soft landing in certain regions bolstered investor sentiment. However, expectations about interest-rate cuts in the United States and Europe diminished amid hawkish comments from the US Federal Reserve and the European Central Bank.



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market.

Data from third party sources may have been used in the preparation of this material and Franklin Templeton Investments (“FTI”) has not independently verified, validated or audited such data. FTI accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FTI affiliates and/or their distributors as local laws and regulation permits. Please consult your own professional adviser or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.